BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 24648346)

  • 1. CLPTM1L promotes growth and enhances aneuploidy in pancreatic cancer cells.
    Jia J; Bosley AD; Thompson A; Hoskins JW; Cheuk A; Collins I; Parikh H; Xiao Z; Ylaya K; Dzyadyk M; Cozen W; Hernandez BY; Lynch CF; Loncarek J; Altekruse SF; Zhang L; Westlake CJ; Factor VM; Thorgeirsson S; Bamlet WR; Hewitt SM; Petersen GM; Andresson T; Amundadottir LT
    Cancer Res; 2014 May; 74(10):2785-95. PubMed ID: 24648346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CLPTM1L/CRR9 ectodomain interaction with GRP78 at the cell surface signals for survival and chemoresistance upon ER stress in pancreatic adenocarcinoma cells.
    Clarke WR; Amundadottir L; James MA
    Int J Cancer; 2019 Mar; 144(6):1367-1378. PubMed ID: 30468251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CircFOXK2 Promotes Growth and Metastasis of Pancreatic Ductal Adenocarcinoma by Complexing with RNA-Binding Proteins and Sponging MiR-942.
    Wong CH; Lou UK; Li Y; Chan SL; Tong JH; To KF; Chen Y
    Cancer Res; 2020 Jun; 80(11):2138-2149. PubMed ID: 32217695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel Anti-CRR9/CLPTM1L Antibodies with Antitumorigenic Activity Inhibit Cell Surface Accumulation, PI3K Interaction, and Survival Signaling.
    Puskás LG; Mán I; Szebeni G; Tiszlavicz L; Tsai S; James MA
    Mol Cancer Ther; 2016 May; 15(5):985-97. PubMed ID: 26939707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imputation and subset-based association analysis across different cancer types identifies multiple independent risk loci in the TERT-CLPTM1L region on chromosome 5p15.33.
    Wang Z; Zhu B; Zhang M; Parikh H; Jia J; Chung CC; Sampson JN; Hoskins JW; Hutchinson A; Burdette L; Ibrahim A; Hautman C; Raj PS; Abnet CC; Adjei AA; Ahlbom A; Albanes D; Allen NE; Ambrosone CB; Aldrich M; Amiano P; Amos C; Andersson U; Andriole G; Andrulis IL; Arici C; Arslan AA; Austin MA; Baris D; Barkauskas DA; Bassig BA; Beane Freeman LE; Berg CD; Berndt SI; Bertazzi PA; Biritwum RB; Black A; Blot W; Boeing H; Boffetta P; Bolton K; Boutron-Ruault MC; Bracci PM; Brennan P; Brinton LA; Brotzman M; Bueno-de-Mesquita HB; Buring JE; Butler MA; Cai Q; Cancel-Tassin G; Canzian F; Cao G; Caporaso NE; Carrato A; Carreon T; Carta A; Chang GC; Chang IS; Chang-Claude J; Che X; Chen CJ; Chen CY; Chen CH; Chen C; Chen KY; Chen YM; Chokkalingam AP; Chu LW; Clavel-Chapelon F; Colditz GA; Colt JS; Conti D; Cook MB; Cortessis VK; Crawford ED; Cussenot O; Davis FG; De Vivo I; Deng X; Ding T; Dinney CP; Di Stefano AL; Diver WR; Duell EJ; Elena JW; Fan JH; Feigelson HS; Feychting M; Figueroa JD; Flanagan AM; Fraumeni JF; Freedman ND; Fridley BL; Fuchs CS; Gago-Dominguez M; Gallinger S; Gao YT; Gapstur SM; Garcia-Closas M; Garcia-Closas R; Gastier-Foster JM; Gaziano JM; Gerhard DS; Giffen CA; Giles GG; Gillanders EM; Giovannucci EL; Goggins M; Gokgoz N; Goldstein AM; Gonzalez C; Gorlick R; Greene MH; Gross M; Grossman HB; Grubb R; Gu J; Guan P; Haiman CA; Hallmans G; Hankinson SE; Harris CC; Hartge P; Hattinger C; Hayes RB; He Q; Helman L; Henderson BE; Henriksson R; Hoffman-Bolton J; Hohensee C; Holly EA; Hong YC; Hoover RN; Hosgood HD; Hsiao CF; Hsing AW; Hsiung CA; Hu N; Hu W; Hu Z; Huang MS; Hunter DJ; Inskip PD; Ito H; Jacobs EJ; Jacobs KB; Jenab M; Ji BT; Johansen C; Johansson M; Johnson A; Kaaks R; Kamat AM; Kamineni A; Karagas M; Khanna C; Khaw KT; Kim C; Kim IS; Kim JH; Kim YH; Kim YC; Kim YT; Kang CH; Jung YJ; Kitahara CM; Klein AP; Klein R; Kogevinas M; Koh WP; Kohno T; Kolonel LN; Kooperberg C; Kratz CP; Krogh V; Kunitoh H; Kurtz RC; Kurucu N; Lan Q; Lathrop M; Lau CC; Lecanda F; Lee KM; Lee MP; Le Marchand L; Lerner SP; Li D; Liao LM; Lim WY; Lin D; Lin J; Lindstrom S; Linet MS; Lissowska J; Liu J; Ljungberg B; Lloreta J; Lu D; Ma J; Malats N; Mannisto S; Marina N; Mastrangelo G; Matsuo K; McGlynn KA; McKean-Cowdin R; McNeill LH; McWilliams RR; Melin BS; Meltzer PS; Mensah JE; Miao X; Michaud DS; Mondul AM; Moore LE; Muir K; Niwa S; Olson SH; Orr N; Panico S; Park JY; Patel AV; Patino-Garcia A; Pavanello S; Peeters PH; Peplonska B; Peters U; Petersen GM; Picci P; Pike MC; Porru S; Prescott J; Pu X; Purdue MP; Qiao YL; Rajaraman P; Riboli E; Risch HA; Rodabough RJ; Rothman N; Ruder AM; Ryu JS; Sanson M; Schned A; Schumacher FR; Schwartz AG; Schwartz KL; Schwenn M; Scotlandi K; Seow A; Serra C; Serra M; Sesso HD; Severi G; Shen H; Shen M; Shete S; Shiraishi K; Shu XO; Siddiq A; Sierrasesumaga L; Sierri S; Loon Sihoe AD; Silverman DT; Simon M; Southey MC; Spector L; Spitz M; Stampfer M; Stattin P; Stern MC; Stevens VL; Stolzenberg-Solomon RZ; Stram DO; Strom SS; Su WC; Sund M; Sung SW; Swerdlow A; Tan W; Tanaka H; Tang W; Tang ZZ; Tardon A; Tay E; Taylor PR; Tettey Y; Thomas DM; Tirabosco R; Tjonneland A; Tobias GS; Toro JR; Travis RC; Trichopoulos D; Troisi R; Truelove A; Tsai YH; Tucker MA; Tumino R; Van Den Berg D; Van Den Eeden SK; Vermeulen R; Vineis P; Visvanathan K; Vogel U; Wang C; Wang C; Wang J; Wang SS; Weiderpass E; Weinstein SJ; Wentzensen N; Wheeler W; White E; Wiencke JK; Wolk A; Wolpin BM; Wong MP; Wrensch M; Wu C; Wu T; Wu X; Wu YL; Wunder JS; Xiang YB; Xu J; Yang HP; Yang PC; Yatabe Y; Ye Y; Yeboah ED; Yin Z; Ying C; Yu CJ; Yu K; Yuan JM; Zanetti KA; Zeleniuch-Jacquotte A; Zheng W; Zhou B; Mirabello L; Savage SA; Kraft P; Chanock SJ; Yeager M; Landi MT; Shi J; Chatterjee N; Amundadottir LT
    Hum Mol Genet; 2014 Dec; 23(24):6616-33. PubMed ID: 25027329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Candidate locus analysis of the TERT-CLPTM1L cancer risk region on chromosome 5p15 identifies multiple independent variants associated with endometrial cancer risk.
    Carvajal-Carmona LG; O'Mara TA; Painter JN; Lose FA; Dennis J; Michailidou K; Tyrer JP; Ahmed S; Ferguson K; Healey CS; Pooley K; Beesley J; Cheng T; Jones A; Howarth K; Martin L; Gorman M; Hodgson S; ; ; Wentzensen N; Fasching PA; Hein A; Beckmann MW; Renner SP; Dörk T; Hillemanns P; Dürst M; Runnebaum I; Lambrechts D; Coenegrachts L; Schrauwen S; Amant F; Winterhoff B; Dowdy SC; Goode EL; Teoman A; Salvesen HB; Trovik J; Njolstad TS; Werner HM; Scott RJ; Ashton K; Proietto T; Otton G; Wersäll O; Mints M; Tham E; ; Hall P; Czene K; Liu J; Li J; Hopper JL; Southey MC; ; Ekici AB; Ruebner M; Johnson N; Peto J; Burwinkel B; Marme F; Brenner H; Dieffenbach AK; Meindl A; Brauch H; ; Lindblom A; Depreeuw J; Moisse M; Chang-Claude J; Rudolph A; Couch FJ; Olson JE; Giles GG; Bruinsma F; Cunningham JM; Fridley BL; Børresen-Dale AL; Kristensen VN; Cox A; Swerdlow AJ; Orr N; Bolla MK; Wang Q; Weber RP; Chen Z; Shah M; Pharoah PD; Dunning AM; Tomlinson I; Easton DF; Spurdle AB; Thompson DJ
    Hum Genet; 2015 Feb; 134(2):231-45. PubMed ID: 25487306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional characterization of CLPTM1L as a lung cancer risk candidate gene in the 5p15.33 locus.
    James MA; Wen W; Wang Y; Byers LA; Heymach JV; Coombes KR; Girard L; Minna J; You M
    PLoS One; 2012; 7(6):e36116. PubMed ID: 22675468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GOLPH2, a gene downstream of ras signaling, promotes the progression of pancreatic ductal adenocarcinoma.
    Duan J; Li X; Huang S; Zeng Y; He Y; Liu H; Lin D; Lu D; Zheng M
    Mol Med Rep; 2018 Mar; 17(3):4187-4194. PubMed ID: 29344673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic inactivation of IRX4 is responsible for acceleration of cell growth in human pancreatic cancer.
    Chakma K; Gu Z; Abudurexiti Y; Hata T; Motoi F; Unno M; Horii A; Fukushige S
    Cancer Sci; 2020 Dec; 111(12):4594-4604. PubMed ID: 32894817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LRH1 as a driving factor in pancreatic cancer growth.
    Lin Q; Aihara A; Chung W; Li Y; Huang Z; Chen X; Weng S; Carlson RI; Wands JR; Dong X
    Cancer Lett; 2014 Apr; 345(1):85-90. PubMed ID: 24333731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of MTSS1 results in increased metastatic potential in pancreatic cancer.
    Zeleniak AE; Huang W; Brinkman MK; Fishel ML; Hill R
    Oncotarget; 2017 Mar; 8(10):16473-16487. PubMed ID: 28146435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The identification of two regulatory ESCC susceptibility genetic variants in the TERT-CLPTM1L loci.
    Zhou L; Fu G; Wei J; Shi J; Pan W; Ren Y; Xiong X; Xia J; Shen Y; Li H; Yang M
    Oncotarget; 2016 Feb; 7(5):5495-506. PubMed ID: 26716642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of CLPTM1L expression and its effects on migration and invasion of human lung cancer cells.
    Ni Z; Chen Q; Lai Y; Wang Z; Sun L; Luo X; Wang X
    Cancer Biomark; 2016; 16(3):445-52. PubMed ID: 27062701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aspartate β-hydroxylase promotes pancreatic ductal adenocarcinoma metastasis through activation of SRC signaling pathway.
    Ogawa K; Lin Q; Li L; Bai X; Chen X; Chen H; Kong R; Wang Y; Zhu H; He F; Xu Q; Liu L; Li M; Zhang S; Nagaoka K; Carlson R; Safran H; Charpentier K; Sun B; Wands J; Dong X
    J Hematol Oncol; 2019 Dec; 12(1):144. PubMed ID: 31888763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The establishment of a human pancreatic mixed ductal-endocrine carcinoma cell line].
    Hou M; Gao J; Liu T; Cui Q
    Zhonghua Bing Li Xue Za Zhi; 1999 Dec; 28(6):422-6. PubMed ID: 11869555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SPOP suppresses pancreatic cancer progression by promoting the degradation of NANOG.
    Tan P; Xu Y; Du Y; Wu L; Guo B; Huang S; Zhu J; Li B; Lin F; Yao L
    Cell Death Dis; 2019 Oct; 10(11):794. PubMed ID: 31624231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of TMEFF2 in Human Pancreatic Cancer Tissue and the Effects of TMEFF2 Knockdown on Cell, Proliferation, and Apoptosis in Human Pancreatic Cell Lines.
    Li K; Gu W; Xu J; Wang A; Han H
    Med Sci Monit; 2019 May; 25():3238-3246. PubMed ID: 31044775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor growth suppression in pancreatic cancer by a putative metastasis suppressor gene Cap43/NDRG1/Drg-1 through modulation of angiogenesis.
    Maruyama Y; Ono M; Kawahara A; Yokoyama T; Basaki Y; Kage M; Aoyagi S; Kinoshita H; Kuwano M
    Cancer Res; 2006 Jun; 66(12):6233-42. PubMed ID: 16778198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel antisense lncRNA NT5E promotes progression by modulating the expression of SYNCRIP and predicts a poor prognosis in pancreatic cancer.
    Zhang P; Cao M; Zhang Y; Xu L; Meng F; Wu X; Xia T; Chen Q; Shi G; Wu P; Chen L; Lu Z; Yin J; Cai B; Cao S; Miao Y; Jiang K
    J Cell Mol Med; 2020 Sep; 24(18):10898-10912. PubMed ID: 32770626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between CLPTM1L-TERT rs401681 polymorphism and pancreatic cancer risk among Chinese Han population.
    Liu C; Wang Y; Huang H; Wang C; Zhang H; Kong Y; Zhang H
    Tumour Biol; 2014 Jun; 35(6):5453-7. PubMed ID: 24577890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.